TYLER, Texas, May 12, 2025--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company"), a medical technology company specializing in therapeutic devices, today announced findings from a recent ...
The patient expert and patient survey comments described UroShield as simple and easy to use. The patient expert reported several benefits from using UroShield in the past 3 years. These included a ...
NanoVibronix has completed the first phase of a randomised control trial with UroShield, the company’s disposable ultrasound device designed to prevent catheter-associated urinary tract infections.
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, ...
ELMSFORD, N.Y.--(BUSINESS WIRE)-- NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...
UroShield™ reduced Colony Forming Units (CFU) count from >100,000 to 10,000 CFU or less in 25 of 29 patients in the treatment group No reported infections in the treatment group versus 27% symptomatic ...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...
UroShield Demonstrates Significant Reductions in CAUTIs, Catheter Blockages and Hospital Visits TYLER, Texas--(BUSINESS WIRE)-- NanoVibronix, Inc. (NAOV) (the “Company”), a medical technology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results